Subcutaneous or visceral adipose tissue expression of the PPARγ gene is not altered in the fatty (fa/fa) Zucker rat

Metabolism: Clinical and Experimental

Volumn 47, Issue 12, 1998, Pages 1494-1498

  Shimoike, Tomoko ^a   Yanase, Toshihiko ^a   Umeda, Fumio ^a   Ichino, Isao ^a   Takayanagi, Ryoichi ^a   Nawata, Hajime ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RIBONUCLEASE III;

ANIMAL EXPERIMENT; ARTICLE; BASE PAIRING; GENE EXPRESSION REGULATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; INSULIN RESISTANCE; MALE; MOLECULAR CLONING; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; SUBCUTANEOUS FAT;

EID: 0031677584     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90076-2     Document Type: Article

References (31)

1. Tontonoz P, Spiegelman BM: Stimulation of adipogenesis in fibroblasts by PPARγ2, a ligand-activated transcription factor. Cell 79:1147-1156, 1994
2. Zhu Y, Alvarez K, Huang Q: Cloning of a new member of the peroxisome poliferator activated receptor gene family from mouse liver. J Biol Chem 268:26817-26820, 1993
3. Sher T, Yi HF, McBride OW, et al: cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry 32:5598-5604, 1993
4. Kliewer SA, Forman BM, Blumberg B, et al: Differential expression and activation of a family of murine peroxisome proliferator activated receptors. Proc Natl Acad Sci USA 91:7355-7359, 1994
5. Tontonoz P, Hu E, Graves RA, et al: mPPARγ2, tissue-specific regulator of an adipocyte enhancer. Genes Dev 8:1224-1234, 1994
6. Zhu Y, Qi C, Korenberg JR, et al: Structural organization of mouse peroxisome proliferator activated receptor γ (mPPARγ) gene: Alternative promoter use and different splicing yield two mPPARγ isoforms. Proc Natl Acad Sci USA 92:7921-7925, 1995
7. Yanase T, Yashiro T, Takitani K, et al: Differential expression of PPARγ1 and γ2 isoforms in human adipose tissue. Biochem Biophys Res Commun 233:320-324, 1997
8. Eibrecht A, Chen Y, Cullina CA, et al: Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors γ1 and γ2. Biochem Biophys Res Commun 224:431-437, 1996
9. Mukherjee R, Jow L, Croston GE, et al: Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARγ2 versus PPARγ1 and activation with retinoid X receptor agonists and antagonists. J Biol Chem 272:8071-8076, 1997
10. Fajas L, Auboeu D, Raspe E, et al: The organization, promoter analysis, and expression of the human PPARγ gene. J Biol Chem 272:18779-18789, 1997
11. Hu E, Tontonoz P, Spiegelman BM: Transdifferentiation of myoblasts by the adipogenic transcription factors PPARγ and C/EBPα. Proc Natl Acad Sci USA 92:9856-9860, 1995
12. Stevenson RW, Hutson NJ, Krupp MN, et al: Actions of novel antidiabetic agent englitazone in hyperglycemic ob/ob mice. Diabetes 39:1218-1227, 1990
13. Mimura K, Umeda F, Hiramatsu S, et al: Effect of a new oral hypoglycemic agent (CS-045) on metabolic abnormalities and insulin resistance in type 2 diabetes. Diabet Med 11:685-691, 1994
14. Lehmann JM, Moore LB, Smith-Oliver TA, et al: An antidiabetic thiazolidinedione is a high affinity ligand for the nuclear receptor PPARγ. J Biol Chem 270:12953-12956, 1995
15. Zhang B, Berger J, Szalkowski D, et al: Negative regulation of peroxisome proliferator-activated receptor-γ gene expression contributes to the antiadipogenic effects of tumor necrosis factor-α. Mol Endocrinol 101:1457-1466, 1996
16. Vidal-Puig AJ, Jimenez-Linan M, Lowell BB, et al: Regulation of PPAR γ gene expression by nutrition and obesity in rodents. J Clin Invest 97:2553-2561, 1996
17. Vidal-Puig AJ, Considine RV, Jimenez-Linan M, et al: Peroxisome proliferator-activated receptor gene expression in human tissues. Effect of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest 99:2416-2422, 1997
18. Zucker TF, Zucker LM: Hereditary obesity in the rat associated with high serum fat and cholesterol. Proc Soc Exp Biol Med 110:165-171, 1962
19. Zucker LM, Antoniades HN: Insulin and obesity in the Zucker genetically obese rat "fatty." Endocrinology 90:1320-1330, 1972
20. Kobatake T, Matsuzawa Y, Tokunaga K, et al: Metabolic improvement associated with a reduction of abnormal visceral fat caused by a new α-glucosidase inhibitor, AO-128, in Zucker fatty rats. Int J Obes 13:147-154, 1988
21. Shimomura I, Takahashi M, Tokunaga K, et al: Rapid enhancement of acyl-CoA synthetase, LPL, and GLUT-4 mRNAs in adipose tissue of VMH rats. Am J Physiol 270:E995-E1002,1996 (suppl)
22. Matsuzawa Y, Shimomura I, Nakamura T, et al: Pathophysiology and pathogenesis of visceral fat obesity. Ann NY Acad Sci 676:270-278, 1993
23. Inoue K, Hiramatsu S, Hisatomi A, et al: Hypersecretion of amylin from the perfused pancreas of genetically obese (fa/fa) rats and its alteration with aging. Metabolism 42:654-658, 1993
24. Saiki RK, Gelfand DH, Stoffel S, et al: Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-491, 1988
25. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 74:5463-5467, 1977
26. Werman A, Hollenberg A, Solanes G, et al: Ligand-independent activation domain in the N-terminus of peroxisome proliferator-activated receptor γ (PPARγ). J Biol Chem 272:20230-20235, 1997
27. Phillips MS, Liu Q, Hammond HA, et al: Leptin receptor missense mutation in the fatty Zucker rat. Nat Genet 13:18-19, 1996
28. Shimomura I, Tokunaga K, Jiao S, et al: Marked enhancement of acyl-CoA synthetase activity and mRNA, paralleled to lipoprotein lipase mRNA, in adipose tissue of Zucker obese rats (fa/fa). Biochim Biophys Acta 1124:112-118, 1992
29. Maeda K: Anatomical character and gene expression of visceral fat tissue. J Clin Exp Med 184:534-538, 1998
30. Shimomura I, Funahashi T, Takahashi M, et al: Enhanced expression of PAI-1 in visceral fat: Possible contributor to vascular disease in obesity. Nat Med 2:800-803, 1996
31. Park KS, Ciaraldi TP, Abrams-Carter L, et al: PPAR-γ gene expression is elevated in skeletal muscle of obese and type II diabetic subjects. Diabetes 46:1230-1234, 1997